Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Toronto-Dominion Bank (TD) Price & Performance

BioNTech SE - ADRTrade
Toronto-Dominion BankTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Toronto-Dominion Bank — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 8.6× BioNTech SE - ADR's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

BNTXTD
Market Cap
$23.31B$200.48B
Sector
HealthFinancials
52-Week High
$119.34$124.80
52-Week Low
$83.89$72.85
Enterprise Value
$6.60B
Dividend Yield
2.63%

Returns comparison

Trailing returns across standard periods

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Toronto-Dominion Bank

Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.

Read more on TD